Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic characterization of indacaterol, a novel beta 2-adrenoceptor agonist.

British journal of pharmacology - 1 Sept 2009

Sayers I, Hawley J, Stewart C E, Billington C K, Henry A, Leighton-Davies J R, Charlton S J, Hall I P

Abstract excerpt

BACKGROUND AND PURPOSE: Indacaterol is a novel beta(2)-adrenoceptor agonist in development for the treatment of chronic obstructive pulmonary disease. The aim of this study was to investigate the comparative pharmacology of indacaterol in recombinant cells expressing the common polymorphic variants of the human beta(2)-adrenoceptor and in human primary airway smooth muscle (ASM) cells. EXPERIMENTAL APPROACH:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-2 Receptor Agonists
Share to CHO Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cricetulus

Share to Cyclic AMP

Share to Indans

Share to Pharmacogenetics

Share to Quinolones

Share to Receptors, Adrenergic, beta-2

Source

Open in PubMed Open full text

Identifiers

PMID: 19422388
DOI: 10.1111/j.1476-5381.2009.00224.x
PMCID: PMC2795231

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic characterization of indacaterol, a novel beta 2-adrenoceptor agonist.PMID 19422388Read ↗

The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).Semantic proximity Read ↗

Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor-mediated responses in human lung mast cells.Semantic proximity Read ↗

A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptors.Semantic proximity Read ↗

A Four Amino Acid Deletion Polymorphism in the Third Intracellular Loop of the Human α2C-Adrenergic Receptor Confers Impaired Coupling to Multiple EffectorsSemantic proximity Read ↗

Identification of Small Molecule as a High Affinity β2 Agonist Promiscuously Targeting Wild and Mutated (Thr164Ile) β 2 Adrenergic Receptor in the Treatment of Bronchial Asthma.Semantic proximity Read ↗

Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.Semantic proximity Read ↗

Polymorphism of the beta(2)-adrenergic receptor gene and desensitization in human airway smooth muscle.Semantic proximity Read ↗

An asn to lys polymorphism in the third intracellular loop of the human alpha 2A-adrenergic receptor imparts enhanced agonist-promoted Gi coupling.Semantic proximity Read ↗

Do gene polymorphisms alone or in combination affect the function of human beta3-adrenoceptors?Semantic proximity Read ↗

A comparison of the molecular pharmacological properties of current short, long and ultra-long-acting β2-agonists used for asthma and COPD.Semantic proximity Read ↗

Hierarchy of polymorphic variation and desensitization permutations relative to beta 1- and beta 2-adrenergic receptor signaling.Semantic proximity Read ↗

Novel human alpha1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.